Tag: TGEN
-
TGen, NAU study examines body’s antibody response to COVID-19 vaccine
Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system’s past history with other coronaviruses, including those behind the common cold, shapes the patients response, according to a study published today in Cell Reports.
-
Study involving TGen, City of Hope uses DNA in the bloodstream to guide treatment for cancer patients
TGen and City of Hope investigators Kamel Lahouel and Cristian Tomasetti are working on study to help guide cancer treatment.
-
TGen study allows late-stage cancer patients to use their health data to guide care
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.
-
TGen begins testing animals in captivity and nature for COVID-19
Working with state and federal wildlife agencies and private and public zoos across Arizona, the Translational Genomics Research Institute (TGen), part of City of Hope, is testing wild animals in captivity and in nature for SARS-CoV-2, the pathogen that causes COVID-19 in humans.
-
Arizona COVID-19 Genomics Union compile 100,000 sequenced genomes of COVID-19
The Arizona COVID-19 Genomics Union, which includes PBC institutions such as Arizona State University, Northern Arizona University, the Translational Genomics Research Institute and the University of Arizona have successfully compiled 100,000 sequenced genomes of COVID-19 to combat the next pandemic.
-
TGen-led study suggest a drug combination that might prove effective for 1 in 3 glioblastoma patients
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead […]
-
Our Bioscience Economy
InBusiness Greater Phoenix recently looked at the Phoenix bioscience and health care ecosystem, and how the sector is transforming our economy. You can read an excerpt of the piece below. “We […]
-
Phoenix Bioscience Core Newsletter
This is a web version of our weekly Phoenix Bioscience Core Newsletter. Welcome to the Phoenix Bioscience Core’s weekly newsletter, featuring the latest news and announcements from around the PBC, upcoming events, and interesting things happening in the community.
-
Faces + Spaces @ TGen
Meet the rest of the PBC community through our monthly Faces and Spaces networking event. Each month join a small group of staff, researchers and community members from around the PBC to learn about a new area of the campus, upcoming programming and other exciting things happening right in your neighborhood. Grab a cup of…
-
TGen, HonorHealth and Irish biomedical team initiate promising ‘Nieto’ clinical trial against pancreatic cancer
association with HonorHealth Research and Innovation Institute and Systems Biology Ireland (SBI), have begun a clinical trial, testing the combination of two drugs against advanced pancreatic cancer, one of the most deadly and difficult-to-treat malignancies.
